Further evidence for the cross-talk between PI3K/AKT and NRF2 was obtained by microarray data derived from endometrioid carcinomas, showing that PTEN-deficient tumours express high levels of NRF2 and its targets [131]. The gene discussed is NFE2L2; the disease is endometrioid adenocarcinoma.